- SIRT5 promotes non-small cell lung cancer progression by reducing FAB…
Number of the records: 1  

SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level

  1. LI, Zhen. SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2022, 2022, vol. 69, no. 4, s. 909-917.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all